Canada: British Columbia Court Of Appeal Decertifies Pharmaceutical Class Action

In Wakelam v. Wyeth Consumer Healthcare / Wyeth Soins de Sante Inc., 2014 BCCA 36, the British Columbia Court of Appeal overruled a decision certifying a class action involving the sale of cough and cold medicines for use by children.


On December 18, 2008, Health Canada reversed a policy permitting the sale of certain non-prescription cough and cold medicines for use by children. While manufacturers had already withdrawn the products from the market for use in children under age two, Health Canada required relabeling to instruct against use in children under age six.

The plaintiff commenced this action on behalf of "all persons resident in British Columbia who purchased Children's Cough Medicine for use by children under the age of six, that was supplied, offered for sale, advertised or promoted by the Defendants between December 24, 1997, to present." She alleged that, in marketing the medicines for use by children under age six, the defendants engaged in "deceptive acts or practices" contrary to the Business Practices and Consumer Protection Act, (the BPCPA) and made misrepresentations contrary to s. 52 of the Competition Act.

Under the BPCPA, the plaintiff sought the following relief: (i) a declaration pursuant to s. 172(1)(a) that the defendants had engaged in deceptive acts or practices; (ii) an interim and permanent injunction pursuant to s. 172(1)(b); (iii) an order under s. 172(3)(c), requiring the defendants to advertise the particulars of any judgment, declaration, order or injunction against it; (iv) an order under s. 172(3)(a) that the defendants refund all sums paid by the class, or disgorge all revenue made on account of their purchases; and (v) damages under s. 171.

Pursuant to s. 36 of the Competition Act, the plaintiff sought damages and the costs of her investigation with respect to the alleged breach of s. 52.

Also, the plaintiff claimed unjust enrichment, waiver of tort and constructive trust on the basis of the alleged breaches of the BPCPA and the Competition Act.

On December 22, 2011, the action was certified by the British Columbia Supreme Court as a class proceeding on substantially the terms sought by the plaintiff.

The Decision of the Court of Appeal

On the basis of the following findings with respect to several central issues, the court allowed the appeal and decertified the action.

(i) The BPCPA

The court struck the claims of waiver of tort, unjust enrichment and constructive trust insofar as they were based on alleged breaches of the BPCPA. The plaintiff claimed that the defendants breached the BPCPA by supplying, soliciting, offering, advertising and promoting the impugned medicines. However, the court found that there was no legislative intent to create restitutionary causes of action arising from or based on breaches of the BPCPA. Applying the reasoning in Koubi v. Mazda Canada Inc., in which the court held that "anti-enrichment" claims premised on a breach of the BPCPA were not available at law, the plaintiff's claims were bound to fail.

In addition, as conceded by the plaintiff, the claim for constructive trust was foreclosed by the judgment of the Supreme Court of Canada in Pro-Sys Consultants Ltd. v. Microsoft Corporation, (Pro-Sys), which held that a plaintiff must be able to point to a link or causal connection between his or her contribution and the acquisition of specific property and that such a remedy is only available where a monetary award is inappropriate or insufficient.

On a similar basis, the court concluded that a restorative order under s. 172(3)(a) of the BPCPA was not available. This provision allowed for the restoration of property or money in which a person has an interest, but the pleading did not suggest that any such interest could arise in this case. As such, this claim was bound to fail.

The plaintiff's own claim for damages was similarly bound to fail as the requisite causal connection between a contravention of the BPCPA and the plaintiff's loss had not been pleaded.

However, the court was not persuaded that the claims for declaratory or injunctive relief or an order requiring the defendants to advertise the particulars of any order granted against them (under s. 172 of the BPCPA) were bound to fail. The Court did note that "an injunction is unlikely to be granted when, as in this instance, the conduct complained of has already ceased and is unlikely to be repeated."

(ii) The Competition Act

According to the Court of Appeal, there was "nothing in the Competition Act to indicate that Parliament intended that the statutory right of action should be augmented by a general right in consumers to sue in tort or to seek restitutionary remedies on the basis of breaches of Part VI [of the Competition Act]." As with the BPCPA, the plaintiff had claimed waiver of tort, unjust enrichment and constructive trust on the basis of breaches of the Competition Act. The Court of Appeal held that the certification judge erred in finding causes of action where restitutionary remedies were sought based on alleged breaches of the Competition Act. In addition, the court struck the plaintiff's claim for damages under s. 36 of the Competition Act. As the plaintiff had failed to plead material facts supporting a causal connection between a breach of the statute and her loss, the court inferred that she was unable to do so.

(iii) Aggregate Damages

The court also held that s. 29 of the Class Proceedings Act, (the CPA) "does not avail the plaintiff to provide restitutionary claims not otherwise open to her under the [BPCPA] or Competition Act." The Supreme Court of Canada in Pro-Sys held that the aggregate damage provisions of the CPA provide a method to assess the quantum (but not the fact) of damage. They are applicable only once liability has been established. Ultimately, having struck all other claims, the Court left open the possibility of the plaintiff seeking to certify her claims for declaratory or injunctive relief and an advertising order under the BPCPA. However, the Court noted that, "if the purpose of class actions is to redress 'real injuries suffered by real people'..., it is worth asking whether anything meaningful is likely to be achieved by the pursuit of what remains of this lawsuit."

(iv) The Doctrine of Paramountcy

Although the appeal was allowed and the proceeding decertified, the Court of Appeal did find that the certification judge had not erred in rejecting an argument based on the doctrine of paramountcy. The defendants had argued that the consumer protection legislation, BPCPA, was inconsistent with the Food and Drugs Act, (the FDA), such that the doctrine of paramountcy rendered the BPCPA inoperative in this case. Specifically, they claimed that the federal scheme, involving a single, federal "decisional authority" overseeing all aspects of drug marketing, would be frustrated by legislation allowing a provincial regulator to usurp this decisional role. According to the defendants, the federal Ministry of Health has a duty to make available those products that Health Canada has found to be beneficial. However, the court found that the primary purpose of the FDA was to protect public health and safety by monitoring and regulating the marketing, advertisement and labelling of drugs. It was not to compel the marketing of drugs that are judged to be beneficial. The FDA is "primarily permissive" and does not create a specific right in a manufacturer or in a consumer. Therefore, the Court of Appeal found that the application of the BPCPA would not necessarily frustrate the purposes of the FDA.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.